Coston McIsaac & Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Buy |
528
+12
| +2% | +$9.36K | 0.11% | 93 |
|
|
2025
Q1 | $426K | Sell |
516
-3
| -0.6% | -$2.48K | 0.12% | 84 |
|
|
2024
Q4 | $400K | Buy |
519
+2
| +0.4% | +$1.54K | 0.12% | 89 |
|
|
2024
Q3 | $458 | Buy |
517
+1
| +0.2% | +$1 | 0.13% | 84 |
|
|
2024
Q2 | $467K | Hold |
516
| – | – | 0.15% | 75 |
|
|
2024
Q1 | $401K | Buy |
516
+1
| +0.2% | +$777 | 0.13% | 84 |
|
|
2023
Q4 | $300K | Hold |
515
| – | – | 0.1% | 89 |
|
|
2023
Q3 | $276K | Sell |
515
-23
| -4% | -$12.3K | 0.1% | 86 |
|
|
2023
Q2 | $252K | Hold |
538
| – | – | 0.09% | 102 |
|
|
2023
Q1 | $184K | Buy |
538
+157
| +41% | +$53.7K | 0.07% | 113 |
|
|
2022
Q4 | $139 | Hold |
381
| – | – | 0.05% | 143 |
|
|
2022
Q3 | $123K | Hold |
381
| – | – | 0.06% | 136 |
|
|
2022
Q2 | $124K | Buy |
+381
| New | +$124K | 0.07% | 89 |
|